These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1120 related items for PubMed ID: 16148690
21. Hydrostatic pressure in the inner ear fluid compartments and its effects on inner ear function. Böhmer A. Acta Otolaryngol Suppl; 1993; 507():3-24. PubMed ID: 8273452 [Abstract] [Full Text] [Related]
22. In vivo visualized endolymphatic hydrops and inner ear functions in patients with electrocochleographically confirmed Ménière's disease. Gürkov R, Flatz W, Louza J, Strupp M, Ertl-Wagner B, Krause E. Otol Neurotol; 2012 Aug; 33(6):1040-5. PubMed ID: 22772006 [Abstract] [Full Text] [Related]
23. Clinical high-resolution imaging and grading of endolymphatic hydrops in Hydropic Ear Disease at 1.5 T using the two-slice grading for vestibular endolymphatic hydrops in less than 10 min. Gürkov R, Lutsenko V, Babkina T, Valchyshyn S, Situkho M. Eur Arch Otorhinolaryngol; 2022 Feb; 279(2):751-757. PubMed ID: 33687507 [Abstract] [Full Text] [Related]
24. Degenerative changes in the organ of Corti and lateral cochlear wall in experimental endolymphatic hydrops and human Menière's disease. Nadol JB, Adams JC, Kim JR. Acta Otolaryngol Suppl; 1995 Feb; 519():47-59. PubMed ID: 7610892 [Abstract] [Full Text] [Related]
25. Meniere's disease and endolymphatic hydrops without Meniere's symptoms: temporal bone histopathology. Vasama JP, Linthicum FH. Acta Otolaryngol; 1999 Feb; 119(3):297-301. PubMed ID: 10380731 [Abstract] [Full Text] [Related]
26. 3D-real IR MRI of Meniere's disease with partial endolymphatic hydrops. Shi S, Zhou F, Wang W. Am J Otolaryngol; 2019 Feb; 40(4):589-593. PubMed ID: 31113683 [Abstract] [Full Text] [Related]
27. Effects of a nitric oxide synthase Type II inhibitor on compound action potential thresholds in experimental endolymphatic hydrops. Ikino CM, Bittar RS, Sato KM, Capella NM. Otol Neurotol; 2007 Jan; 28(1):111-5. PubMed ID: 17031325 [Abstract] [Full Text] [Related]
28. Electrocochleography and gentamicin therapy for Ménière's disease: a preliminary report. Adamonis J, Stanton SG, Cashman MZ, Mattan K, Nedzelski JM, Chen JM. Am J Otol; 2000 Jul; 21(4):534-42. PubMed ID: 10912700 [Abstract] [Full Text] [Related]
30. Clinical Features and Endolymphatic Hydrops in Patients With MRI Evidence of Hydrops. Shi S, Guo P, Li W, Wang W. Ann Otol Rhinol Laryngol; 2019 Apr; 128(4):286-292. PubMed ID: 30556402 [Abstract] [Full Text] [Related]
31. Temporal bone findings in a case of bilateral Menière's disease treated by parenteral streptomycin and endolymphatic shunt. Khetarpal U, Schuknecht HF. Laryngoscope; 1990 Apr; 100(4):407-14. PubMed ID: 2319892 [Abstract] [Full Text] [Related]
32. [Quantification of endolymphatic hydrops in experimental animal model]. Liang Q, Chi FL. Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Jan; 39(1):32-5. PubMed ID: 15127566 [Abstract] [Full Text] [Related]
33. The relationship between endolymphatic hydrops features and hearing loss in Bilateral Meniere's disease. Liu X, Wang D, Hsieh YL, Shi S, Wang W. Head Face Med; 2024 Sep 16; 20(1):50. PubMed ID: 39285461 [Abstract] [Full Text] [Related]
34. A human temporal bone study of changes in the basilar membrane of the apical turn in endolymphatic hydrops. Nageris B, Adams JC, Merchant SN. Am J Otol; 1996 Mar 16; 17(2):245-52. PubMed ID: 8723956 [Abstract] [Full Text] [Related]
35. The quantification of endolymphatic hydrops in an experimental animal model with guinea pigs. Chi FL, Liang Q. ORL J Otorhinolaryngol Relat Spec; 2004 Mar 16; 66(2):56-61. PubMed ID: 15162001 [Abstract] [Full Text] [Related]
36. Relationship Between the Extent of Endolymphatic Hydrops and the Severity and Fluctuation of Audiovestibular Symptoms in Patients With Menière's Disease and MRI Evidence of Hydrops. Jerin C, Floerke S, Maxwell R, Gürkov R. Otol Neurotol; 2018 Feb 16; 39(2):e123-e130. PubMed ID: 29315188 [Abstract] [Full Text] [Related]
37. Lack of diagnostic value of high-pass noise masking of auditory brainstem responses in Ménière's disease. De Valck CF, Claes GM, Wuyts FL, Van de Heyning PH. Otol Neurotol; 2007 Aug 16; 28(5):700-7. PubMed ID: 17667775 [Abstract] [Full Text] [Related]
38. A mouse model with postnatal endolymphatic hydrops and hearing loss. Megerian CA, Semaan MT, Aftab S, Kisley LB, Zheng QY, Pawlowski KS, Wright CG, Alagramam KN. Hear Res; 2008 Mar 16; 237(1-2):90-105. PubMed ID: 18289812 [Abstract] [Full Text] [Related]
39. Ménière's disease: a long-term follow-up study of bilateral hearing levels. Takumida M, Kakigi A, Takeda T, Anniko M. Acta Otolaryngol; 2006 Sep 16; 126(9):921-5. PubMed ID: 16864488 [Abstract] [Full Text] [Related]
40. Delayed endolymphatic hydrops as a clinical entity. Kamei T. Int Tinnitus J; 2004 Sep 16; 10(2):137-43. PubMed ID: 15732511 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]